GlassScriptPhysician profile
Philip Mcclure
NPI 1740418912
$149,935.45
in general payments reported to CMS, 2019-2025
14 companies · $8,818 in 2025
The $8,818 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $21K · 2021: $34K · 2022: $21K · 2023: $18K · 2024: $20K · 2025: $8,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $35K · Travel and Lodging: $11K · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $35,371.25 |
| Travel and Lodging | $11,388.49 |
| Food and Beverage | $698.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $112,538.71 | 2019-2025 | Truelok, Tl-Hex Truelok Hexapod System, Sambascrew |
| Smith+Nephew, INC. | $16,203.23 | 2019-2025 | Maverick, Spatial Frame, Renasys Touch |
| Orthopediatrics Corp. | $10,766.29 | 2022-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $7,776.05 | 2020-2023 | Precice Intramedullary Limb Lengthening System |
| Wishbone Medical INC. | $1,375.00 | 2023 | Femoral Nail |
| Medical Device Business Services, INC. | $900.00 | 2021 | |
| Seaspine Orthopedics Corporation | $138.40 | 2022 | |
| Globus Medical, INC. | $130.54 | 2024 | Mars 3v/3vl, Creo One Robotic Screw, Coalition Agx / Agx Rp |
| Solventum Corporation | $30.73 | 2025 | Activ.A.C. |
| Depuy Synthes Sales INC. | $25.51 | 2021 | |
| Abbvie INC. | $21.54 | 2022 | |
| Kyowa Kirin, INC. | $17.34 | 2025 | |
| Biomarin Pharmaceutical INC. | $12.11 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.